In Silico Clinical Trials Market, Global Outlook and Forecast 2023-2028

Report ID: 1424035 | Published Date: Sep 2024 | No. of Page: 64 | Base Year: 2023 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 In Silico Clinical Trials Market Definition
    1.2 Market Segments
        1.2.1 Market by Phase
        1.2.2 Market by Application
    1.3 Global In Silico Clinical Trials Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global In Silico Clinical Trials Overall Market Size
    2.1 Global In Silico Clinical Trials Market Size: 2021 VS 2028
    2.2 Global In Silico Clinical Trials Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top In Silico Clinical Trials Players in Global Market
    3.2 Top Global In Silico Clinical Trials Companies Ranked by Revenue
    3.3 Global In Silico Clinical Trials Revenue by Companies
    3.4 Top 3 and Top 5 In Silico Clinical Trials Companies in Global Market, by Revenue in 2021
    3.5 Global Companies In Silico Clinical Trials Product Type
    3.6 Tier 1, Tier 2 and Tier 3 In Silico Clinical Trials Players in Global Market
        3.6.1 List of Global Tier 1 In Silico Clinical Trials Companies
        3.6.2 List of Global Tier 2 and Tier 3 In Silico Clinical Trials Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Phase - Global In Silico Clinical Trials Market Size Markets, 2021 & 2028
        4.1.2 Phase I
        4.1.3 Phase II
        4.1.4 Phase III
        4.1.5 Phase IV
    4.2 By Phase - Global In Silico Clinical Trials Revenue & Forecasts
        4.2.1 By Phase - Global In Silico Clinical Trials Revenue, 2017-2022
        4.2.2 By Phase - Global In Silico Clinical Trials Revenue, 2023-2028
        4.2.3 By Phase - Global In Silico Clinical Trials Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global In Silico Clinical Trials Market Size, 2021 & 2028
        5.1.2 Oncology
        5.1.3 Infectious Disease
        5.1.4 Hematology
        5.1.5 Cardiology
        5.1.6 Dermatology
        5.1.7 Neurology
        5.1.8 Diabetes
        5.1.9 Others
    5.2 By Application - Global In Silico Clinical Trials Revenue & Forecasts
        5.2.1 By Application - Global In Silico Clinical Trials Revenue, 2017-2022
        5.2.2 By Application - Global In Silico Clinical Trials Revenue, 2023-2028
        5.2.3 By Application - Global In Silico Clinical Trials Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global In Silico Clinical Trials Market Size, 2021 & 2028
    6.2 By Region - Global In Silico Clinical Trials Revenue & Forecasts
        6.2.1 By Region - Global In Silico Clinical Trials Revenue, 2017-2022
        6.2.2 By Region - Global In Silico Clinical Trials Revenue, 2023-2028
        6.2.3 By Region - Global In Silico Clinical Trials Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America In Silico Clinical Trials Revenue, 2017-2028
        6.3.2 US In Silico Clinical Trials Market Size, 2017-2028
        6.3.3 Canada In Silico Clinical Trials Market Size, 2017-2028
        6.3.4 Mexico In Silico Clinical Trials Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe In Silico Clinical Trials Revenue, 2017-2028
        6.4.2 Germany In Silico Clinical Trials Market Size, 2017-2028
        6.4.3 France In Silico Clinical Trials Market Size, 2017-2028
        6.4.4 U.K. In Silico Clinical Trials Market Size, 2017-2028
        6.4.5 Italy In Silico Clinical Trials Market Size, 2017-2028
        6.4.6 Russia In Silico Clinical Trials Market Size, 2017-2028
        6.4.7 Nordic Countries In Silico Clinical Trials Market Size, 2017-2028
        6.4.8 Benelux In Silico Clinical Trials Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia In Silico Clinical Trials Revenue, 2017-2028
        6.5.2 China In Silico Clinical Trials Market Size, 2017-2028
        6.5.3 Japan In Silico Clinical Trials Market Size, 2017-2028
        6.5.4 South Korea In Silico Clinical Trials Market Size, 2017-2028
        6.5.5 Southeast Asia In Silico Clinical Trials Market Size, 2017-2028
        6.5.6 India In Silico Clinical Trials Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America In Silico Clinical Trials Revenue, 2017-2028
        6.6.2 Brazil In Silico Clinical Trials Market Size, 2017-2028
        6.6.3 Argentina In Silico Clinical Trials Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa In Silico Clinical Trials Revenue, 2017-2028
        6.7.2 Turkey In Silico Clinical Trials Market Size, 2017-2028
        6.7.3 Israel In Silico Clinical Trials Market Size, 2017-2028
        6.7.4 Saudi Arabia In Silico Clinical Trials Market Size, 2017-2028
        6.7.5 UAE In Silico Clinical Trials Market Size, 2017-2028
7 Players Profiles
    7.1 Certara, Inc.
        7.1.1 Certara, Inc. Corporate Summary
        7.1.2 Certara, Inc. Business Overview
        7.1.3 Certara, Inc. In Silico Clinical Trials Major Product Offerings
        7.1.4 Certara, Inc. In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.1.5 Certara, Inc. Key News
    7.2 Novadiscovery Sas
        7.2.1 Novadiscovery Sas Corporate Summary
        7.2.2 Novadiscovery Sas Business Overview
        7.2.3 Novadiscovery Sas In Silico Clinical Trials Major Product Offerings
        7.2.4 Novadiscovery Sas In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.2.5 Novadiscovery Sas Key News
    7.3 Insilico Medicine, Inc.
        7.3.1 Insilico Medicine, Inc. Corporate Summary
        7.3.2 Insilico Medicine, Inc. Business Overview
        7.3.3 Insilico Medicine, Inc. In Silico Clinical Trials Major Product Offerings
        7.3.4 Insilico Medicine, Inc. In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.3.5 Insilico Medicine, Inc. Key News
    7.4 Dassault Systemes SE
        7.4.1 Dassault Systemes SE Corporate Summary
        7.4.2 Dassault Systemes SE Business Overview
        7.4.3 Dassault Systemes SE In Silico Clinical Trials Major Product Offerings
        7.4.4 Dassault Systemes SE In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.4.5 Dassault Systemes SE Key News
    7.5 GNS Healthcare Inc.
        7.5.1 GNS Healthcare Inc. Corporate Summary
        7.5.2 GNS Healthcare Inc. Business Overview
        7.5.3 GNS Healthcare Inc. In Silico Clinical Trials Major Product Offerings
        7.5.4 GNS Healthcare Inc. In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.5.5 GNS Healthcare Inc. Key News
    7.6 The AnyLogic Company
        7.6.1 The AnyLogic Company Corporate Summary
        7.6.2 The AnyLogic Company Business Overview
        7.6.3 The AnyLogic Company In Silico Clinical Trials Major Product Offerings
        7.6.4 The AnyLogic Company In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.6.5 The AnyLogic Company Key News
    7.7 InSilicoTrials
        7.7.1 InSilicoTrials Corporate Summary
        7.7.2 InSilicoTrials Business Overview
        7.7.3 InSilicoTrials In Silico Clinical Trials Major Product Offerings
        7.7.4 InSilicoTrials In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.7.5 InSilicoTrials Key News
    7.8 Immunetrics Inc.
        7.8.1 Immunetrics Inc. Corporate Summary
        7.8.2 Immunetrics Inc. Business Overview
        7.8.3 Immunetrics Inc. In Silico Clinical Trials Major Product Offerings
        7.8.4 Immunetrics Inc. In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.8.5 Immunetrics Inc. Key News
    7.9 Nuventra Pharma Sciences
        7.9.1 Nuventra Pharma Sciences Corporate Summary
        7.9.2 Nuventra Pharma Sciences Business Overview
        7.9.3 Nuventra Pharma Sciences In Silico Clinical Trials Major Product Offerings
        7.9.4 Nuventra Pharma Sciences In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.9.5 Nuventra Pharma Sciences Key News
    7.10 Abzena Ltd.
        7.10.1 Abzena Ltd. Corporate Summary
        7.10.2 Abzena Ltd. Business Overview
        7.10.3 Abzena Ltd. In Silico Clinical Trials Major Product Offerings
        7.10.4 Abzena Ltd. In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.10.5 Abzena Ltd. Key News
    7.11 Siemens
        7.11.1 Siemens Corporate Summary
        7.11.2 Siemens Business Overview
        7.11.3 Siemens In Silico Clinical Trials Major Product Offerings
        7.11.4 Siemens In Silico Clinical Trials Revenue in Global Market (2017-2022)
        7.11.5 Siemens Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
List of Tables
    Table 1. In Silico Clinical Trials Market Opportunities & Trends in Global Market
    Table 2. In Silico Clinical Trials Market Drivers in Global Market
    Table 3. In Silico Clinical Trials Market Restraints in Global Market
    Table 4. Key Players of In Silico Clinical Trials in Global Market
    Table 5. Top In Silico Clinical Trials Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global In Silico Clinical Trials Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global In Silico Clinical Trials Revenue Share by Companies, 2017-2022
    Table 8. Global Companies In Silico Clinical Trials Product Type
    Table 9. List of Global Tier 1 In Silico Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 In Silico Clinical Trials Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Phase – Global In Silico Clinical Trials Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Phase - In Silico Clinical Trials Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Phase - In Silico Clinical Trials Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global In Silico Clinical Trials Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - In Silico Clinical Trials Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - In Silico Clinical Trials Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global In Silico Clinical Trials Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global In Silico Clinical Trials Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global In Silico Clinical Trials Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America In Silico Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America In Silico Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe In Silico Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe In Silico Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia In Silico Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia In Silico Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America In Silico Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America In Silico Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa In Silico Clinical Trials Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa In Silico Clinical Trials Revenue, (US$, Mn), 2023-2028
    Table 30. Certara, Inc. Corporate Summary
    Table 31. Certara, Inc. In Silico Clinical Trials Product Offerings
    Table 32. Certara, Inc. In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 33. Novadiscovery Sas Corporate Summary
    Table 34. Novadiscovery Sas In Silico Clinical Trials Product Offerings
    Table 35. Novadiscovery Sas In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 36. Insilico Medicine, Inc. Corporate Summary
    Table 37. Insilico Medicine, Inc. In Silico Clinical Trials Product Offerings
    Table 38. Insilico Medicine, Inc. In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 39. Dassault Systemes SE Corporate Summary
    Table 40. Dassault Systemes SE In Silico Clinical Trials Product Offerings
    Table 41. Dassault Systemes SE In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 42. GNS Healthcare Inc. Corporate Summary
    Table 43. GNS Healthcare Inc. In Silico Clinical Trials Product Offerings
    Table 44. GNS Healthcare Inc. In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 45. The AnyLogic Company Corporate Summary
    Table 46. The AnyLogic Company In Silico Clinical Trials Product Offerings
    Table 47. The AnyLogic Company In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 48. InSilicoTrials Corporate Summary
    Table 49. InSilicoTrials In Silico Clinical Trials Product Offerings
    Table 50. InSilicoTrials In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 51. Immunetrics Inc. Corporate Summary
    Table 52. Immunetrics Inc. In Silico Clinical Trials Product Offerings
    Table 53. Immunetrics Inc. In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 54. Nuventra Pharma Sciences Corporate Summary
    Table 55. Nuventra Pharma Sciences In Silico Clinical Trials Product Offerings
    Table 56. Nuventra Pharma Sciences In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 57. Abzena Ltd. Corporate Summary
    Table 58. Abzena Ltd. In Silico Clinical Trials Product Offerings
    Table 59. Abzena Ltd. In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
    Table 60. Siemens Corporate Summary
    Table 61. Siemens In Silico Clinical Trials Product Offerings
    Table 62. Siemens In Silico Clinical Trials Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. In Silico Clinical Trials Segment by Phase in 2021
    Figure 2. In Silico Clinical Trials Segment by Application in 2021
    Figure 3. Global In Silico Clinical Trials Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global In Silico Clinical Trials Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global In Silico Clinical Trials Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by In Silico Clinical Trials Revenue in 2021
    Figure 8. By Phase - Global In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 9. By Application - Global In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 10. By Region - Global In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 11. By Country - North America In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 12. US In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 16. Germany In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 17. France In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 24. China In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 28. India In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 30. Brazil In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa In Silico Clinical Trials Revenue Market Share, 2017-2028
    Figure 33. Turkey In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE In Silico Clinical Trials Revenue, (US$, Mn), 2017-2028
    Figure 37. Certara, Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Novadiscovery Sas In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Insilico Medicine, Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Dassault Systemes SE In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GNS Healthcare Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. The AnyLogic Company In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. InSilicoTrials In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Immunetrics Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Nuventra Pharma Sciences In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Abzena Ltd. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Siemens In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
64
Frequently Asked Questions
In Silico Clinical Trials Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
In Silico Clinical Trials Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
In Silico Clinical Trials Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports